HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hydrocodone Polistirex And Chlorpheniramine Polistirex, and when can generic versions of Hydrocodone Polistirex And Chlorpheniramine Polistirex launch?
Hydrocodone Polistirex And Chlorpheniramine Polistirex is a drug marketed by Tris Pharma Inc and is included in one NDA.
The generic ingredient in HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX is chlorpheniramine polistirex; hydrocodone polistirex. There are twenty-nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the chlorpheniramine polistirex; hydrocodone polistirex profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX?
- What are the global sales for HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX?
- What is Average Wholesale Price for HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX?
Summary for HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 2 |
| Patent Applications: | 21 |
| DailyMed Link: | HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX at DailyMed |
Recent Clinical Trials for HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mallinckrodt | Phase 1 |
See all HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX clinical trials
Pharmacology for HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX
| Drug Class | Histamine-1 Receptor Antagonist Opioid Agonist |
| Mechanism of Action | Histamine H1 Receptor Antagonists Opioid Agonists |
US Patents and Regulatory Information for HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tris Pharma Inc | HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX | chlorpheniramine polistirex; hydrocodone polistirex | SUSPENSION, EXTENDED RELEASE;ORAL | 091632-001 | Oct 1, 2010 | RX | No | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
